BEIJING, Nov. 28, 2022 (GLOBE NEWSWIRE) — The Global Autoimmune Disease Diagnostics Market The size accounted for USD 4.4 billion in 2021 and is expected to occupy a market size of USD 8.2 billion by 2030, growing at a CAGR of 7.2% from 2022 to 2030.
Autoimmune Disease Diagnostics Market Statistics
- The global autoimmune disease diagnostics market revenue was USD 4.4 billion in 2021, growing at a CAGR of 7.2% from 2022 to 2030
- North America region accounted for 34.9% of autoimmune disease diagnostics market share in 2021
- Asia-Pacific Autoimmune Disease Diagnostics Market Growth Expected to Increase at a CAGR of 8% from 2022 to 2030
- By end use, the hospital sector captures more than 52.2% of the total market share in 2021
- Growing adoption of laboratory automation technologies is driving the market value of autoimmune disease diagnostics
Free Sample Report Request @ https://www.acumenresearchandconsulting.com/request-sample/1177
Autoimmune Disease Diagnostics Market Report cover:
|Market||Autoimmune Disease Diagnostics Market|
|Autoimmune Disease Diagnostics Market Size 2021||$4.4 billion|
|Autoimmune Disease Diagnostics Market Forecast 2030||$8.2 billion|
|Autoimmune Disease Diagnostics Market CAGR from 2022 to 2030||7.2%|
|Autoimmune Disease Diagnostics Market Analysis period||2018 – 2030|
|Autoimmune Disease Diagnostics Market base year||2021|
|Autoimmune Disease Diagnostics Market Forecast data||2022 – 2030|
|Segments Covered||By product, by test type, by end use and by geography|
|Autoimmune Disease Diagnostics Market Regional scope||North America, Europe, Asia-Pacific, Latin America, Middle East and Africa|
|Profiled Key Companies||AstraZeneca, Inova Diagnostics Inc., Novartis AG, Abbott Laboratories, Pfizer Inc., F. Hoffmann-La Roche, Bio-Rad Laboratories Inc., Hemagen Diagnostics Inc., Beckman Coulter Inc. and Sanofi-aventis.|
|Report cover||Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulatory Analysis|
Autoimmune Disease Diagnostics Market Overview
Autoimmune diseases are caused by the body’s unique immunological responses, which result in antibodies that target its own tissues and cells. Normally, this leads to the breakdown and weakening of healthy tissue. Some of the procedures used to diagnose autoimmune diseases include autoantibody test, antinuclear antibody measurement, complete blood count, erythrocyte sedimentation rate, as well as C-reactive protein.
Autoimmune Disease Diagnostics Market Trends
Increasing disease occurrences, increasing demand for better and more accurate diagnostic procedures, increasing adoption of advanced rapid recognition, various development activities, and initiatives by favorable federal regulations are some of the key factors. growth of the global autoimmune disease diagnostics market. North America is expected to grow at the fastest rate during the forecast period owing to the availability of a wide range of improved and more accurate disease diagnostic procedures, early acceptance of various sophisticated diagnostics and continuous technological developments in the healthcare sector. Awareness campaigns organized by various organizations are also contributing significantly to expanding the geographic market for autoimmune disease diagnostics.
Rising Incidence of Diseases and Demand for More Accurate Diagnostic Procedures to Drive the Growth of the Global Autoimmune Disease Diagnostics Market
Rising incidence of diseases such as Hashimoto’s thyroiditis and rheumatoid arthritis, along with various government efforts, are some of the major drivers for the growth of the global autoimmune disease diagnostics market. According to the American Autoimmune Related Diseases Association, approximately 50 million people worldwide are currently affected by autoimmune diseases. During the projected period, this aspect is expected to generate the huge potential of the global autoimmune disease diagnostics market. The growing demand for better and more accurate diagnostic processes as the incidence of various diseases increases is expected to drive the use of autoimmune disease diagnostic techniques in the forecast period. Autoimmune diseases are still poorly understood. The government funds extensive research and development to produce superior diagnostic and treatment procedures. These research efforts are expected to drive further market expansion. Several measures aimed at reducing the cost of curing these disorders are also expected to drive the overall market growth through the forecasted period. Currently, organizations such as Johns Hopkins and the Autoimmune Research Network (ARNet) Autoimmune Disease Research Center are conducting research in this area. These organizations mainly focus on creating various ways to cope with increasing economic pressure. The American Autoimmune Related Diseases Association has also undertaken various activities to raise awareness of the benefits of early diagnosis.
View the report’s detailed table of contents @
Autoimmune Disease Diagnostics Market Segmentation
The global autoimmune disease diagnostics market has been segmented by Acumen Research and Consulting on the basis of product, type of test and end use. By product, the segment is separated into systemic (multiple sclerosis, rheumatoid arthritis, psoriasis, systemic lupus erythematosus (SLE) and others) and localized (inflammatory bowel disease, thyroid, type 1 diabetes and others). According to the autoimmune disease diagnostics market forecast, the localized category is expected to grow significantly over the next few years.
In terms of test type, the market is categorized into antinuclear antibody tests, c-reactive protein (CRP), urinalysis, autoantibody tests, complete blood count (CBC) and others. Further, the market is divided into diagnostic centers, hospitals and others based on the end use.
Regional Overview of Autoimmune Disease Diagnostics Market
Based on region, segmentation of the global autoimmune disease diagnostics market is done into North America, Asia-Pacific, Europe, Middle East & Africa and Latin America. According to an analysis of the autoimmune disease diagnostics industry, North America is expected to generate the most revenue and grow at the fastest CAGR over the projection period. This expansion is due to the availability of a variety of better and more reliable disease diagnostic procedures, the rapid adoption of many sophisticated diagnostic techniques, and continuous technical improvements in the healthcare industry. Awareness campaigns organized by various organizations are also contributing immensely to the economic growth of the domestic autoimmune disease diagnostics market. Rising preferences for more advanced disease diagnostic technologies, along with rapid growth in the healthcare industry, are driving the growth of the regional market.
Additionally, Asia-Pacific is expected to grow significantly over the projection period due to the existence of a huge patient base and increasing discretionary funds in emerging markets. Some of the important drivers for the expansion of the regional market include the building of infrastructure and the early and growing requirement for accurate diagnosis.
Buy this premium research report –
Autoimmune Disease Diagnostics Market Players
The autoimmune disease diagnostics industry is highly consolidated, with a significant number of manufacturers. Company profiles of leading market players contain important business strategies, company overviews, and revenue. Some of the major companies in the autoimmune disease diagnostics market are Abbott Laboratories, Beckman Coulter Inc., F. Hoffmann-La Roche, Inova Diagnostics Inc., Pfizer Inc., AstraZeneca, Bio-Rad Laboratories Inc., Hemagen Diagnostics Inc. ., Novartis AG , and Sanofi-aventis.
Questions this report answers
- What was the market size of the Autoimmune Disease Diagnostics Market in 2021?
- What will be the CAGR of the Autoimmune Disease Diagnostics Market during the forecast period from 2022 to 2030?
- Who are the key players in the Global Autoimmune Disease Diagnostics Market?
- Which region held the largest Autoimmune Disease Diagnostics market share in 2021?
- What are the key market drivers of the Autoimmune Disease Diagnostics Market?
- Who is the largest end-user of Autoimmune Disease Diagnostics Market?
- What will be the value of the Autoimmune Disease Diagnostics Market in 2030?
Browse more research topics on Health sector Related:
The Global Capnography Device market Size taken into account $513 million in 2021 and is expected to reach a market size of $1,134 million By 2030, grow to a 9.3% CAGR from 2022 to 2030.
The Global walking aids market taken into account $6,210 million in 2021 and is expected to reach the market value of $8,711 million by 2030 to a CAGR of 4.0% during the forecast period from 2022 to 2030.
The Global Elderly and Disabled Assistive Devices Market Size is rated at $22,439 million in 2021 and is expected to reach a market size of $37,263 million by 2030; grow to one CAGR of 5.9%.
About Acumen Research and Consulting:
Acumen Research and Consulting is a global provider of information and consulting services in the information technology, investment, telecommunications, manufacturing and consumer technology markets. ARC helps investment communities, IT professionals, and business leaders make fact-based decisions about technology purchases and develop business growth strategies to compete in the marketplace . With a team of over 100 analysts and a collective industry experience of over 200 years, Acumen Research and Consulting ensures to provide a combination of industry knowledge with global and national level expertise.
For the latest update, follow us on Twitter , instagram and LinkedIn
Mr. Richard Johnson
Acumen Research and Consulting
#autoimmune #disease #diagnostics #market #size #expected #reach #USD #billion #registering #CAGR #driven #increasing #prevalence #autoimmune #diseases